A Novel Fluorescent Imaging Agent for Diffuse Optical Tomography of the Breast: First Clinical Experience in Patients

PURPOSE: This is the first clinical evaluation of a novel fluorescent imaging agent (Omocianine) for breast cancer detection with diffuse optical tomography (DOT). PROCEDURES: Eleven women suspected of breast cancer were imaged with DOT at multiple time points (up to 24 h) after receiving an intrave...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Ven, Stephanie, Wiethoff, Andrea, Nielsen, Tim, Brendel, Bernhard, van der Voort, Marjolein, Nachabe, Rami, Van der Mark, Martin, Van Beek, Michiel, Bakker, Leon, Fels, Lueder, Elias, Sjoerd, Luijten, Peter, Mali, Willem
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864903/
https://www.ncbi.nlm.nih.gov/pubmed/19798535
http://dx.doi.org/10.1007/s11307-009-0269-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864903/
https://www.ncbi.nlm.nih.gov/pubmed/19798535
http://dx.doi.org/10.1007/s11307-009-0269-1

Ejemplares similares